In the univariate analysis of the effects of PTX3 genetic variants and clinicopathological characteristics on patient survival, although cervical cancer patients with the genotype CC in rs2120243 and the genotype GG in PTX3 rs1840680 had a higher chance of developing adenocarcinoma, no PTX3 variants were found to be predictive of 5 years survival. The gene discussed is PTX3; the disease is adenocarcinoma.